Sports concussion management sits at one of the most consequential intersections in clinical practice, where rapid decisions affect neurological recovery, athlete safety, and long-term outcomes. Yet the dominant tools in the field, automated computerized testing platforms like ImPACT and KingDevick, were designed primarily for scalability rather than clinical depth. As return-to-play laws expand across states and regulatory expectations tighten, clinicians working in sports medicine, functional neurology, chiropractic, physical therapy, and athletic training need concussion baseline protocols and absence of suspicion documentation tools that actually reflect how the nervous system responds to trauma.

This course bridges that gap. Built directly from the clinical program at the University of Cincinnati, it presents a neuro-based pre-participation baseline panel that integrates oculomotor function, saccadic eye movement assessment, optical coherence tomography, peripheral vision reaction time via Dynavision, near point of convergence, vestibular screening, and Maddox rod phoria testing into a cohesive, repeatable system. Clinicians learn not only how to administer each test, but why each measurement was selected and what it reveals about underlying neurological status that symptom checklists and computerized reaction time scores cannot capture.

A centerpiece of the course is the Absence of Suspicion Test, a peer-reviewed, published protocol designed to help qualified clinicians document clearance decisions following a suspected concussive event. In states like Ohio where specific documentation of absence of suspicion is now legally required, this tool provides a defensible, quantitative record generated in approximately seven minutes using equipment available in nearly any sports medicine or clinical setting.

This course is designed for licensed clinicians including physical therapists, chiropractors, athletic trainers, optometrists, and other qualified practitioners who work with student athletes or active populations and want to move beyond surface-level concussion screening toward baseline strategies that serve patients at every severity level.